ANDA 84581, held by Ivax Sub Teva Pharms. Hydralazine Hydrochloride.
As of Nov 16, 2026, ANDA 84581 (Hydralazine Hydrochloride), held by Ivax Sub Teva Pharms, was first approved by FDA on Sep 12, 1975, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 12, 1975 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydralazine Hydrochloride100MG ยท tablet;oral | Hydralazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters